| Adalimumab for refractory pulmonary sarcoidosis PA Minnis, M Poland, MP Keane, SC Donnelly Irish Journal of Medical Science (1971-) 185, 969-971, 2016 | 17 | 2016 |
| Serum exosomes from IPF patients display a fibrotic miRNA profile that correlates to clinical measures of disease severity P Minnis, R Kane, R Anglin, S Walsh, J Worrel, F Khan, RV Lumsden, ... European Respiratory Journal 46 (suppl 59), 2015 | 14 | 2015 |
| Answering the Skeptic’s Question PE Minnis, BJ Little, R Kelly, SE Ingram, LS Dean Snow, KA Spielmann The SAA Archaeological Record 6 (5), 17-20, 2006 | 12 | 2006 |
| Antifibrotic therapy in idiopathic pulmonary fibrosis T Scullion, P Gorman, E Gibson, R Kelly, E Murtagh, P Minnis The Ulster medical journal 86 (1), 73, 2017 | 7 | 2017 |
| P242 pirfenidone as a bridge to lung transplantation in patients with progressive ipf P Riddell, P Minnis, P Ging, JJ Egan Thorax 69 (Suppl 2), A183-A183, 2014 | 7 | 2014 |
| Reflux in idiopathic pulmonary fibrosis P Minnis, K Henry, MP Keane QJM: An International Journal of Medicine 109 (1), 7-10, 2016 | 4 | 2016 |
| A rare cause of cystic lung disease–Birt-Hogg-Dubé syndrome P Minnis, P Riddell, MP Keane Respiratory Medicine Case Reports 18, 90-92, 2016 | 3 | 2016 |
| The use of pirfenidone in combination with sildenafil for advanced idiopathic pulmonary fibrosis P Riddell, P Minnis, J Egan A38. DIAMONDS ARE FOREVER BUT NEW TREATMENTS FOR INTERSTITIAL LUNG DISEASE …, 2014 | 3 | 2014 |
| Predicting progression of RA-ILD using anti-CCP P Minnis, K Henry, B Clark, MP Keane European Respiratory Journal 46 (suppl 59), 2015 | 2 | 2015 |
| Real-world experience of nintedanib for progressive fibrosing interstitial lung disease in the UK G Dixon, S Hague, S Mulholland, H Adamali, AMN Khin, H Thould, ... ERJ Open Research 10 (1), 2024 | 1 | 2024 |
| S120 Serum MicroRNA profiles in IPF patients–biomarkers or potential therapeutic targets? P Minnis, R Kane, R Lumsden, S Whitty, SC Donnelly, MP Keane Thorax 70 (Suppl 3), A68-A69, 2015 | 1 | 2015 |
| P151 Neutrophil Lymphocyte ratio to predict in-patient mortality of Pulmonary Embolism during the SARS-CoV-2 pandemic R Connon, M Shiel, S McNeill, C Ferguson, P Minnis Thorax 78 (Suppl 4), A198-A199, 2023 | | 2023 |
| P225 Airway disease in pulmonary sarcoidosis C McCool, B Flanagan, L Graham, K Kerr, P Minnis Thorax 78 (Suppl 4), A247-A248, 2023 | | 2023 |
| P195 Lung texture analysis in pulmonary fibrosis and emphysema B Flanagan, C McCool, L Graham, V Steele, E Gibson, R Kelly, E Murtagh, ... Thorax 78 (Suppl 4), A227-A228, 2023 | | 2023 |
| P193 Diabetes and progression in pulmonary fibrosis M Shiel, M Basil, L Graham, E Murtagh, P Minnis Thorax 78 (Suppl 4), A226-A226, 2023 | | 2023 |
| Real-world data from 24 UK centres for the use of nintedanib for progressive fibrosing interstitial lung disease G Dixon, S Hague, S Mulholland, AMN Khin, H Thould, R Connon, ... European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| Lung Texture Analysis to phenotype Sarcoidosis C Mccool, A Mccorkell, V Steele, L Graham, R Kelly, E Murtagh, P Minnis European Respiratory Journal 62 (suppl 67), 2023 | | 2023 |
| RB-ILD: More common than we thought? C Cruickshank, M Donaghy, E Murtagh, P Minnis IRISH JOURNAL OF MEDICAL SCIENCE 190 (SUPPL 5), 162-162, 2021 | | 2021 |
| P2 Geographical variation of interstitial lung disease in the northern trust M Donaghy, S Gilmour, E Murtagh, P Minnis Thorax 76 (Suppl 2), A67-A68, 2021 | | 2021 |
| P148 The comorbidome of sarcoidosis S Gilmour, M Donaghy, P Minnis, E Murtagh Thorax 76 (Suppl 2), A148-A148, 2021 | | 2021 |
